Literature DB >> 17340610

Aripiprazole augmentation of incomplete treatment response in an adolescent male with obsessive-compulsive disorder.

Eric A Storch1, Heather Lehmkuhl, Gary R Geffken, Alexis Touchton, Tanya K Murphy.   

Abstract

We report the case of adolescent male with obsessive-compulsive disorder (OCD) who had an incomplete response to combined cognitive-behavioral therapy (CBT) and sertraline before successful augmentation of CBT with aripiprazole. Standardized assessments indicated significant reductions in OCD symptomatology associated with both initial treatment and aripiprazole augmentation. This case suggests that aripiprazole may have utility as an augmenting agent of CBT in adolescents with OCD and underscores the need for conducting controlled studies to test this hypothesis. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17340610     DOI: 10.1002/da.20303

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  9 in total

1.  Successful Treatment Response with Aripiprazole Augmentation of SSRIs in Refractory Obsessive-Compulsive Disorder in Childhood.

Authors:  Ulku Akyol Ardic; Eyup Sabri Ercan; Ayse Kutlu; Deniz Yuce; Melis Ipci; Sevim Berrin Inci
Journal:  Child Psychiatry Hum Dev       Date:  2017-10

2.  Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: a 14-week, prospective, open-label study.

Authors:  Kimberly A Stigler; Jonathan T Diener; Arlene E Kohn; Lang Li; Craig A Erickson; David J Posey; Christopher J McDougle
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-06       Impact factor: 2.576

3.  Focus on aripiprazole: a review of its use in child and adolescent psychiatry.

Authors:  Masa'il Greenaway; Dean Elbe
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2009-08

Review 4.  Children with obsessive-compulsive disorder: are they just "little adults"?

Authors:  Simran K Kalra; Susan E Swedo
Journal:  J Clin Invest       Date:  2009-04-01       Impact factor: 14.808

5.  Aripiprazole augmentation in patients with resistant obsessive compulsive disorder: a pilot study.

Authors:  Roberto Delle Chiaie; Pierluigi Scarciglia; Massimo Pasquini; Maria Caredda; Massimo Biondi
Journal:  Clin Pract Epidemiol Ment Health       Date:  2011-05-27

Review 6.  Efficacy and safety of aripiprazole in child and adolescent patients.

Authors:  Eiji Kirino
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-03-25       Impact factor: 4.785

Review 7.  Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD).

Authors:  Antonio Del Casale; Serena Sorice; Alessio Padovano; Maurizio Simmaco; Stefano Ferracuti; Dorian A Lamis; Chiara Rapinesi; Gabriele Sani; Paolo Girardi; Georgios D Kotzalidis; Maurizio Pompili
Journal:  Curr Neuropharmacol       Date:  2019       Impact factor: 7.363

8.  Evidence-based pharmacotherapy for pediatric obsessive-compulsive disorder and chronic tic disorders.

Authors:  Alessandro S De Nadai; Eric A Storch; Joseph F McGuire; Adam B Lewin; Tanya K Murphy
Journal:  J Cent Nerv Syst Dis       Date:  2011-06-01

9.  Obsessive-Compulsive Disorder Presenting with Compulsions to Urinate Frequently.

Authors:  Stephen Amarjeet Jiwanmall; Dheeraj Kattula
Journal:  Indian J Psychol Med       Date:  2016 Jul-Aug
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.